Dilazep, a vasodilator that is used to treat patients with hypertension, cardiovascular, and renovascular disorders, is a second pharmaceutical agent that blocks GATA2 DNA-binding, suppresses the expression of AR, and reduces tumor growth in a murine xenograft model of CRPC (50). This evidence concerns the gene GATA2 and neoplasm.